This site is intended only for healthcare professionals resident in the Republic of Ireland




Sign in or registerLog out
Our medicinesTherapy areasExplore contentExplore contentMaterialsVideosPodcastsLet’s connectLet's connectContact usSign up



About Oncology Biosimilars
Heritage of Innovation
Oncology Biosimilar ProductsSupport & ResourcesMaterialsVideos
Heritage of InnovationCommitted to biosimilars

Pfizer has the experience and resources to develop and manufacture biosimilar medicines

Biosimilar medicines are part of the future of biologic treatment, and Pfizer Biosimilars is committed to working at every level to make the full potential of biosimilar medicines a reality across the communities we serve.

For 30 years, Pfizer has dedicated significant resources to providing high-quality biologic medicines and selecting exceptional supply partners, with a development program supported by robust clinical and analytical data. Pfizer continues building on this through Pfizer Biosimilars, leveraging nearly 10 years of additional experience with biosimilars outside the United States.1,2

References: 1. Pfizer. Data on File. 2. Biosimilars approved in Europe. GaBi Online. (n.d.). Retrieved September 27, 2022, from
PP-RIT-IRL-0051. Date of preparation May 2023

Adverse events should be reported. Report an adverse event to your national reporting system (HPRA Pharmacovigilance)

Adverse events should also be reported to Pfizer Medical Information on 1800 633 363

PfizerPro AccountPfizerPro Account

Please sign in or register to gain access to information relating to Pfizer medicines and vaccines, medical conditions, patient materials and services.

Sign in or RegisterRegisterAccountLog out

This site is intended only for healthcare professionals resident in the Republic of Ireland. If you are a member of the public wishing to access information on a specific medicine, please visit


This website is brought to you by Pfizer Healthcare Ireland, 9 Riverwalk, National Digital Park, Citywest Business Campus, Dublin 24, Ireland. Registered in the Republic of Ireland No. 127002.


Copyright © 2023 Pfizer Limited. All rights reserved.

PP-UNP-IRL-0176. January 2023
You are now leaving PfizerPro
You are now leaving PfizerPro Ireland. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer. Pfizer accepts no responsibility for the content or services of the linked site.
PP-UNP-IRL-0176. January 2023
For Healthcare Professionals in the Republic of Ireland *

The information contained on this site is reserved exclusively for healthcare professionals resident in the Republic of Ireland.

I confirm that I am a healthcare professional resident in the Republic of Ireland.*

I accept and agree to the terms of use.*

If you select 'No', you will be redirected to, where you will be able to access information on Pfizer Healthcare Ireland.

PP-UNP-IRL-0176. January 2023

Yes No